NCT03856112 2019-03-26Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapsed or Refractory Multiple MyelomaNational Cancer Institute (NCI)Phase 1/2 Withdrawn
NCT02951117 2017-06-05A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer TreatmentAbbViePhase 1 Withdrawn